Sai Parenterals enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast closeFY26Mar 2026
2,139—
417417
4.44.4
319319
2,045—
−97.5−97.5
₹462.97—
815815
39.2%39.2%
0.16×—
5.37×—
52.86×—
93.63×—
21.98×—
74.24×—
74.24×—
Reference items — trailing FY values
381381
38.738.7
21.821.8
93.193.1
27.627.6
27.627.6
65.565.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SAIPARENT₹484.05

Sai Parenterals Limited

· Pharma & Health
₹ CrorePeersINDOCOPANACEABIOHIKALWINDLASHESTERBIODCALSYNCOMFSOLARAMcap ₹2,139 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Current
last close
Market Capitalization—2,138.5
- Cash, Equiv & ST Investments417.0417.0
+ Minority Interest4.44.4
+ Total Debt319.5319.5
Enterprise Value—2,045.4
Net Debt (memo)-97.5-97.5
EV per Share—462.97
Total Capital814.6814.6
Total Debt/Total Capital39.2239.22
Total Debt/EV—0.16
EV/Sales—5.37
EV/EBITDA—52.86
EV/EBIT—93.63
EV/Operating Cash Flow—21.98
EV/Free Cash Flow—74.24
EV/FCFF—74.24
Reference Items — Trailing FY Values
Sales381.0381.0
EBITDA38.738.7
EBIT21.821.8
Operating Cash Flow93.193.1
Free Cash Flow27.627.6
FCFF (free cash flow to the firm)27.627.6
Capital Expenditure65.565.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.